A detailed history of Linscomb & Williams, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Linscomb & Williams, Inc. holds 8,170 shares of GILD stock, worth $767,571. This represents 0.03% of its overall portfolio holdings.

Number of Shares
8,170
Previous 9,246 11.64%
Holding current value
$767,571
Previous $634,000 7.89%
% of portfolio
0.03%
Previous 0.03%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$66.59 - $83.99 $71,650 - $90,373
-1,076 Reduced 11.64%
8,170 $684,000
Q2 2024

Aug 07, 2024

SELL
$63.15 - $72.88 $10,356 - $11,952
-164 Reduced 1.74%
9,246 $634,000
Q1 2024

May 14, 2024

SELL
$71.58 - $87.29 $72,796 - $88,773
-1,017 Reduced 9.75%
9,410 $689,000
Q4 2023

Feb 06, 2024

SELL
$73.27 - $83.09 $19,416 - $22,018
-265 Reduced 2.48%
10,427 $844,000
Q3 2023

Oct 10, 2023

SELL
$73.94 - $80.67 $49,244 - $53,726
-666 Reduced 5.86%
10,692 $801,000
Q2 2023

Aug 09, 2023

SELL
$76.01 - $86.7 $137,882 - $157,273
-1,814 Reduced 13.77%
11,358 $875,000
Q1 2023

May 11, 2023

SELL
$77.31 - $88.08 $381,911 - $435,115
-4,940 Reduced 27.27%
13,172 $1.09 Million
Q4 2022

Feb 14, 2023

SELL
$62.32 - $89.47 $30,536 - $43,840
-490 Reduced 2.63%
18,112 $1.55 Million
Q3 2022

Nov 09, 2022

BUY
$59.54 - $68.01 $11,312 - $12,921
190 Added 1.03%
18,602 $1.15 Million
Q2 2022

Aug 15, 2022

SELL
$57.72 - $65.01 $20,663 - $23,273
-358 Reduced 1.91%
18,412 $1.14 Million
Q1 2022

May 17, 2022

SELL
$57.92 - $72.58 $540,335 - $677,098
-9,329 Reduced 33.2%
18,770 $1.12 Million
Q4 2021

Feb 10, 2022

BUY
$64.88 - $73.64 $148,121 - $168,120
2,283 Added 8.84%
28,099 $2.04 Million
Q3 2021

Nov 03, 2021

BUY
$67.69 - $73.03 $85,627 - $92,382
1,265 Added 5.15%
25,816 $1.8 Million
Q2 2021

Aug 10, 2021

BUY
$63.47 - $69.35 $185,840 - $203,056
2,928 Added 13.54%
24,551 $1.69 Million
Q1 2021

May 12, 2021

BUY
$60.0 - $68.46 $69,180 - $78,934
1,153 Added 5.63%
21,623 $1.4 Million
Q4 2020

Feb 11, 2021

BUY
$56.65 - $64.55 $142,134 - $161,955
2,509 Added 13.97%
20,470 $1.19 Million
Q3 2020

Nov 13, 2020

BUY
$62.1 - $78.08 $85,139 - $107,047
1,371 Added 8.26%
17,961 $1.14 Million
Q2 2020

Aug 11, 2020

BUY
$72.34 - $84.0 $477,009 - $553,896
6,594 Added 65.97%
16,590 $1.28 Million
Q1 2020

May 11, 2020

BUY
$62.63 - $80.22 $146,804 - $188,035
2,344 Added 30.63%
9,996 $747,000
Q4 2019

Feb 13, 2020

BUY
$61.62 - $67.78 $97,421 - $107,160
1,581 Added 26.04%
7,652 $497,000
Q3 2019

Nov 08, 2019

BUY
$62.51 - $69.0 $15,314 - $16,905
245 Added 4.21%
6,071 $385,000
Q2 2019

Aug 06, 2019

BUY
$61.87 - $69.38 $5,197 - $5,827
84 Added 1.46%
5,826 $394,000
Q1 2019

May 09, 2019

BUY
$62.53 - $70.05 $9,066 - $10,157
145 Added 2.59%
5,742 $373,000
Q4 2018

Feb 08, 2019

SELL
$60.54 - $79.0 $88,206 - $115,103
-1,457 Reduced 20.65%
5,597 $350,000
Q3 2018

Nov 08, 2018

BUY
$71.28 - $78.92 $24,948 - $27,622
350 Added 5.22%
7,054 $545,000
Q2 2018

Aug 07, 2018

BUY
$64.88 - $75.68 $19,269 - $22,476
297 Added 4.64%
6,704 $475,000
Q1 2018

May 04, 2018

BUY
$72.84 - $88.8 $509 - $621
7 Added 0.11%
6,407 $483,000
Q4 2017

Feb 02, 2018

BUY
$71.15 - $83.52 $25,187 - $29,566
354 Added 5.86%
6,400 $459,000
Q3 2017

Oct 27, 2017

BUY
$72.11 - $85.47 $435,977 - $516,751
6,046
6,046 $490,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $118B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Linscomb & Williams, Inc. Portfolio

Follow Linscomb & Williams, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Linscomb & Williams, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Linscomb & Williams, Inc. with notifications on news.